Ministry of Truth (Globalist MSM) brand Didier Raoult's Chloroquine cure
'Fake News'
Newsletter published on March 26, 2020
My webpage Coronavirus Remedies - Chloroqu
ine and Herbal Medicines
is now up, at http://mailstar.net/coronavirus-remedies.html
It contains the material I sent out about Natural Remedies, in recent days.
The material in this newsletter is there too.
(1) Ministry of Truth (Globalist MSM) brand Didier Raoult's Chloroquine
cure 'Fake News'
(2) Patent Bypass law allows a company to copy a patented medicine
without consent
(3) Extend restrictions to delay Second Wave of COVID-19
(4) Recovered patients have Lung damage
(1) Ministry of Truth (Globalist MSM) brand Didier Raoult's Chloroquine
cure 'Fake News'
This scientist suggested a drug to treat Covid-19. 'Fact checkers'
branded him fake news
Nebojsa Malic is a Serbian-American journalist, blogger and translator,
who wrote a regular column for Antiwar.com from 2000 to 2015, and is now
senior writer at RT. Follow him on Twitter @NebojsaMalic
Mar 26, 2020
Amid a pandemic panic over the coronavirus, evidence for a possibly
effective treatment has been denounced as 'fake news' – even when
offered by a renowned scientist with decades of experience.
Take Didier Raoult, a French microbiologist with undeniable expertise,
even if some of his views are about as eccentric as his appearance.
Though he may look like he just stepped out of an Alexandre Dumas novel,
the director of the Mediterranean University Hospital Institute in
Marseille cited not one but three different studies from China showing
that the anti-malaria drug called chloroquine has been effective in
treating Covid-19 patients.
#chloroquine Pr Didier Raoult : «C'est quand les patients ont des
formes modérées, moyennes, ou qui commencent à s'aggraver, qu'il faut
les traiter. A ce moment là on contrôle les virus qui se multiplient.
Quand ils sont rentrés en réanimation, le problème ce n'est plus le
virus» pic.twitter.com/WolGe2o05z
— Alex (@AlexLeroy90) March 25, 2020
That did not stop Le Monde, France's biggest newspaper, of declaring his
February 25 video as "partially false." Raoult's 'sin' was to argue that
the common anti-malaria drug used widely for decades resulted in
"dramatic improvements" among those afflicted by the virus.
As a result of Le Monde's fact-check, anyone attempting to share Dr.
Raoult's videos on Facebook gets a banner saying the information therein
was "partially false" as "determined by independent fact-checkers."
The main argument put forward by those critical of the drug is that more
testing is required before it can be officially approved as treatment
for the coronavirus. As the US Centers for Disease Control and
Prevention (CDC) puts it, "There are no currently available data from
Randomized Clinical Trials…to inform clinical guidance on the use,
dosing, or duration of hydroxychloroquine" treatments for Covid-19.
Which is fair enough, but last time I checked, there was a pandemic
going on, with billions of people locked in their homes and all business
grinding to a halt across the globe, over apocalyptic predictions of
hospitals brimming with corpses due to this coronavirus.
Should any kind of treatment – especially a drug that has been used
safely for decades to treat something else, with side effects
meticulously documented – be so cavalierly rejected, under the
circumstances? Do "experts" really think the world has the luxury of
waiting for months or even years for their controlled lab studies?
As for the fact-checkers, shouldn't they have applied the same rigor to
the models used to scare everyone into hoarding toilet paper and setting
off a depression orders of magnitude worse than anything the world has
ever seen?
To ask these questions is to answer them, yet no one seems to bother.
Nor is this sort of selective blindness endemic to France; across the
Atlantic, the mainstream media raised their voices in unison against
chloroquine after US President Donald Trump brought it up as a possible
treatment – apparently referring to Dr. Raoult's work.
They went so far as to widely circulate a deliberately misleading story
about an Arizona couple that ate fish tank cleaner – chloroquine
phosphate, clearly labeled not for human consumption – as somehow
Trump's fault. Some of them quietly amended it to specify the
difference, but long after the original story – implying they took the
actual medication praised by the president – literally went viral and
poisoned the minds of millions.
Worse yet, as a result of this media blitz, the governor of Nevada
actually banned using chloroquine to treat Covid-19 patients this week,
saying there was "no consensus among experts or Nevada doctors" that the
anti-malaria drug can treat coronavirus sufferers. There were no angry
editorials denouncing Steve Sisolak, a Democrat, for letting people die
or the coronavirus rather than have them treated with a drug endorsed by
the Republican president and the media's favorite hate object.
One would think the world paralyzed with fear of the invisible death
would pounce on every possible solution, no matter how unlikely it
seems. That's what we're shown in Hollywood disaster movies, after all.
Yet when such a solution presents itself, it is dismissed and denounced
as "not proven"!
We're supposed to blindly trust apocalyptic models produced by
panic-mongering political hacks, but ignore the man who says the drug
brought him back from the brink of death, even though his story can be
easily verified and theirs cannot.
"Preferring opinions to facts is a disease," Dr. Raoult told the French
magazine Marianne last week. Just so.
I don't know if hydroxychloroquine works on Covid-19. Dr. Raoult seems
to believe so, and he's not alone. In the absence of better solutions –
and locking billions of people in their homes indefinitely is not one –
don't we owe humanity to at least try? What do we have to lose?
In the three months or so since the coronavirus first appeared in China,
there has been a lot of conflicting, confusing and outright false
information about it. One thing that has consistently proven true,
however, is that the biggest obstacle in effectively battling its spread
and treating the afflicted has been the obtuse insistence of the
political and medical establishment on blindly following their rules. If
the virus is truly threatening to kill millions, as they say, they would
not value procedures over saving lives. Nevertheless, they persist. It
makes one wonder why.
(2) Patent Bypass law allows a company to copy a patented medicine
without consent
A Canadian bill would make it easier to issue compulsory licenses for
Covid-19 products
By Ed Silverman @Pharmalot
March 25, 2020
J. Scott Applewhite/AP
In response to the pandemic, Canadian lawmakers have passed a bill that
would speed the process of issuing compulsory licenses for medical
products, adding to a list of countries seeking to ensure access to
medicines and devices, among other items.
A country may grant such a license to a public agency or a generic drug
maker, allowing it to copy a patented medicine without the consent of
the brand-name company that owns the patent. This right was memorialized
in a section of a World Trade Organization agreement known as the
Trade-Related Aspects of Intellectual Property Rights, or TRIPS.
Actually, Canadian law already permits the government to issue a
compulsory license, but the bill would essentially speed the process by
allowing the country to move much faster to secure a license in the
event of a public health crisis. Rather than the undergoing the usual
process of haggling with a company over terms, the government could
simply issue a license and negotiate compensation later (see part 12).
"What they’ve done is procedural but significant because a company won’t
be able to fight about a license upfront, which means the government can
use it immediately," explained Richard Gold, a law professor at McGill
University in Montreal who focuses on life sciences and intellectual
property. "It’s signaling to everyone the government won’t put up with
delays if there’s a public health emergency."
For now, he added, the move seems designed to ensure access to personal
protective equipment in situations where price gouging occurs or a
company is unable to handle orders. In such cases, the government could
issue a license to another company to make the products. The bill passed
the Senate and House of Commons and is awaiting the signature of
Governor General of Canada Julie Payette.
A spokeswoman for Innovative Medicines Canada wrote us that the trade
group, which represents brand-name drug makers, is still reviewing the
bill and does not have a comment. As for generic companies, the Canadian
Generic Pharmaceutical Association, not surprisingly, supports the measure.
"The ability of a country to issue compulsory licenses for medicines and
other urgently needed items to respond to a health crisis is not a novel
approach, and is embedded in international trade agreements such as the
WTO Agreement on the Trade-Related Aspects of Intellectual Property
Rights. This is a prudent and reasonable precautionary measure," said
Jim Keon, who heads the group, in a statement.
(3) Extend restrictions to delay Second Wave of COVID-19
March 25, 2020 / 7:32 PM
Longer social distancing period may delay second wave of COVID-19
By Brian P. Dunleavy
March 25 (UPI) -- A phased return to normalcy and relaxing of social
distancing measures may delay the expected second wave of COVID-19
infections in the United States, suggests an analysis from Wuhan, China,
where the new coronavirus pandemic began.
Published Wednesday in the journal The Lancet Public Health, the
modeling study looked at the outbreak in the central Chinese city in
which lockdown measures were introduced in late January.
With rates of new infections in the region slowing dramatically in
recent weeks, officials in China have revealed plans to begin this month
rolling back restrictions on movement and public gatherings, reopening
transit hubs, restaurants and other businesses.
However, the new findings suggest that by removing these outbreak
containment safeguards now, the country risks seeing a second wave of
COVID-19 infections as soon as late August, increasing the burden on its
already beleaguered healthcare system.
Waiting until April to dial back the restrictions could postpone this
second wave until October, researchers said.
"The unprecedented measures the city of Wuhan has put in place to reduce
social contacts in school and the workplace have helped to control the
outbreak," study co-author Dr. Kiesha Prem, a professor at the London
School of Hygiene and Tropical Medicine, said in a press release.
"However, the city now needs to be really careful to avoid prematurely
lifting physical distancing measures, because that could lead to an
earlier secondary peak in cases. But if they relax the restrictions
gradually, this is likely to both delay and flatten the peak." RELATED
Study: Social distancing might reduce COVID-19 spread by as much as 99%
The findings could be viewed as a warning for the United States, where
several cities have introduced social distancing measures and closed
schools to stem the spread of the virus.
(4) Recovered patients have Lung damage
COVID-19: Recovered patients have partially reduced lung function
Chinese researchers have found fluid- or debris-filled sacs in the lungs
of those who were infected by COVID-19. Scans suggest sustained organ
damage.
More than 86,000 people worldwide have now recovered from the lung
disease COVID-19. In those cases, the infection manifested itself in
mild to moderate form, or it is because these patients received
excellent medical care.
This number can provide solace, on the one hand, but on the other there
is still little information about how these people are doing after the
infection has run its course.
With great relief and joy, some convalescents describe how they have
survived the physical, but above all psychological stress: the healing
of symptoms, the agonizing uncertainty, and the gruelling isolation
phase. They are happy to be immune to SARS-CoV-2 after having survived
the illness. Relief is often mixed with apprehension — for instance,
with regard to the many people who have not yet been infected.
Complete recovery?
As the new coronavirus generally affects the lower respiratory tract,
most of those infected exhibit a dry cough, shortness of breath or
pneumonia.
A small study of 12 patients discharged from hospital showed that two or
three had reduced lung function. However, it is too early to confirm any
long-term effects.
"In some patients, lung function could decline by about 20 to 30% after
recovery," says Dr. Owen Tsang Tak-yin, medical director of the
Infectious Diseases Centre at Princess Margaret Hospital in Hong Kong.
Computer tomography have shown fluid- or debris-filled sacs in the
lungs, which may get progressively worse as the illness develops.
The findings from Hong Kong confirm very early investigations from Wuhan
in early February 2020. In a recent study, scientists from Zhongnam
Hospital of Wuhan University analyzed 140 lung scans of COVID-19
patients and found a ground glass opacity in both lungs of each patient.
Suspected pulmonary fibrosis
Further investigations of the recovered COVID-19 patients must now be
conducted to show whether they have developed pulmonary fibrosis —
scarring in the lungs. Over time, the scar tissue can destroy the normal
lung and make it hard for oxygen to get into the blood. Low oxygen
levels (and the stiff scar tissue itself) can cause shortness of breath,
particularly during physical exertion.
Lung fibrosis cannot be cured because the scarred changes in the lung
tissue do not regress. But the progression of pulmonary fibrosis can be
delayed and sometimes even stopped if detected in time.
1
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.